UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The factor VIII treatment history of non‐severe hemophilia A: COMMENT. Joint damage in adult patients with mild or moderate hemophilia A evaluated with the HEAD‐US system

Journal of thrombosis and haemostasis, 2021-10, Vol.19 (10), p.2638-2641

2021

Volltextzugriff (PDF)

Current state and potential applications of neonatal Fc receptor (FcRn) inhibitors in hematologic conditions

American journal of hematology, 2024-12, Vol.99 (12), p.2351-2366

2024

Volltextzugriff (PDF)

Prophylaxis therapy with bypassing agents in patients with haemophilia A and inhibitors undergoing surgery: A cost analysis in Spain

European journal of haematology, 2020-07, Vol.105 (1), p.94-100

2020

Volltextzugriff (PDF)

Ultrasound evaluation of joint damage and disease activity in adult patients with severe haemophilia A using the HEAD‐US system

Haemophilia : the official journal of the World Federation of Hemophilia, 2021-05, Vol.27 (3), p.479-487

2021

Volltextzugriff (PDF)

Adherence to prophylaxis in adult patients with severe haemophilia A

Haemophilia : the official journal of the World Federation of Hemophilia, 2020-09, Vol.26 (5), p.800-808

2020

Volltextzugriff (PDF)

Humanistic burden of haemophilia A without inhibitors: A cross‐sectional analysis of the HemoLIFE study

Haemophilia : the official journal of the World Federation of Hemophilia, 2024-07, Vol.30 (4), p.950-958

2024

Volltextzugriff (PDF)

Novel Therapies to Address Unmet Needs in ITP

Pharmaceuticals (Basel, Switzerland), 2022-06, Vol.15 (7), p.779

2022

Volltextzugriff (PDF)

COVID-19 Vaccines and Autoimmune Hematologic Disorders

Vaccines (Basel), 2022-06, Vol.10 (6), p.961

2022

Volltextzugriff (PDF)

Type 2N VWD: Conclusions from the Spanish PCM‐EVW‐ES project

Haemophilia : the official journal of the World Federation of Hemophilia, 2021-11, Vol.27 (6), p.1007-1021

2021

Volltextzugriff (PDF)

P1614: TAPERING SCHEME AND SUSTAINED RESPONSE IN PATIENTS WITH ITP TREATED WITH FOSTAMATINIB

HemaSphere, 2023-08, Vol.7 (S3), p.e35944fd-n/a

2023

Volltextzugriff (PDF)

P1609: CAPLACIZUMAB THERAPY IN OLDER PATIENTS (≥60 YEARS) WITH IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA (ITTP). RESULTS OF THE SPANISH TTP REGISTRY

HemaSphere, 2023-08, Vol.7 (S3), p.e61163bd-n/a

2023

Volltextzugriff (PDF)

S305: PHASE 2 RANDOMIZED, PLACEBO‐CONTROLLED, DOUBLE‐BLIND, MULTICENTER STUDY OF RECOMBINANT ADAMTS13 IN PATIENTS WITH IMMUNE‐MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA

HemaSphere, 2023-08, Vol.7 (S3), p.e8651306-n/a

2023

Volltextzugriff (PDF)

Evans syndrome in adults: an observational multicenter study

Blood advances, 2021-12, Vol.5 (24), p.5468-5478

2021

Volltextzugriff (PDF)

Spanish consensus guidelines on prophylaxis with bypassing agents for surgery in patients with haemophilia and inhibitors

European journal of haematology, 2016-05, Vol.96 (5), p.461-474

2016

Volltextzugriff (PDF)

Multicenter assessment and longitudinal study of the prevalence of antibodies and related adaptive immune responses to AAV in adult males with hemophilia

Gene therapy, 2024-05, Vol.31 (5-6), p.273-284

2024

Volltextzugriff (PDF)

Avatrombopag plus fostamatinib combination as treatment in patients with multirefractory immune thrombocytopenia

British journal of haematology, 2024-10, Vol.205 (4), p.1551-1555

2024

Volltextzugriff (PDF)

Multirefractory primary immune thrombocytopenia; targeting the decreased sialic acid content

Platelets (Edinburgh), 2019-08, Vol.30 (6), p.743-751

2019

Volltextzugriff (PDF)

Sustained Remission in Patients with Primary Immune Thrombocytopenia after Romiplostim Tapering and Discontinuation: A Case Series in Real Life Management in Spain

Case reports in hematology, 2017-01, Vol.2017 (2017), p.1-8

2017

Volltextzugriff (PDF)

International recommendations on the diagnosis and treatment of patients with acquired hemophilia A

Haematologica (Roma), 2009-04, Vol.94 (4), p.566-575

2009

Volltextzugriff (PDF)

Efficacy and safety in patients with haemophilia A switching to octocog alfa (BAY 81–8973): Final results of the global real‐world study, TAURUS

European journal of haematology, 2023-01, Vol.110 (1), p.77-87

2023

Volltextzugriff (PDF)

BAY 81‐8973 prophylaxis and pharmacokinetics in haemophilia A: Interim results from the TAURUS study

European journal of haematology, 2020-08, Vol.105 (2), p.164-172

2020

Volltextzugriff (PDF)

Acquired Haemophilia A: A Review of What We Know

Journal of blood medicine, 2022-11, Vol.13, p.691-710

2022

Volltextzugriff (PDF)

New treatments for primary immune thrombocytopenia

Blood coagulation & fibrinolysis, 2022-01, Vol.33 (Suppl 1), p.S8-S11

Mingot-Castellano, María Eva

2022

Volltextzugriff (PDF)

An update on the pathogenesis and diagnosis of thrombotic thrombocytopenic purpura

Expert review of hematology, 2023-01, Vol.16 (1), p.17-32

2023

Volltextzugriff (PDF)

Sovleplenib in immune thrombocytopenia

The Lancet. Haematology, 2024-08, Vol.11 (8), p.e552-e553

Mingot-Castellano, María Eva

2024

Volltextzugriff (PDF)

1 – 25 von 94

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(89)
Mit Volltextzugriff
(75)

Publikationsform

Artikel
(93)
Berichte
(1)

Sprache

Englisch
(90)
Spanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

The factor VIII treatment history of non‐severe hemophilia A: COMMENT. Joint damage in adult patients with mild or moderate hemophilia A evaluated with the HEAD‐US system

Current state and potential applications of neonatal Fc receptor (FcRn) inhibitors in hematologic conditions

Prophylaxis therapy with bypassing agents in patients with haemophilia A and inhibitors undergoing surgery: A cost analysis in Spain

Ultrasound evaluation of joint damage and disease activity in adult patients with severe haemophilia A using the HEAD‐US system

Adherence to prophylaxis in adult patients with severe haemophilia A

Humanistic burden of haemophilia A without inhibitors: A cross‐sectional analysis of the HemoLIFE study

Novel Therapies to Address Unmet Needs in ITP

COVID-19 Vaccines and Autoimmune Hematologic Disorders

Type 2N VWD: Conclusions from the Spanish PCM‐EVW‐ES project

P1614: TAPERING SCHEME AND SUSTAINED RESPONSE IN PATIENTS WITH ITP TREATED WITH FOSTAMATINIB

P1609: CAPLACIZUMAB THERAPY IN OLDER PATIENTS (≥60 YEARS) WITH IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA (ITTP). RESULTS OF THE SPANISH TTP REGISTRY

S305: PHASE 2 RANDOMIZED, PLACEBO‐CONTROLLED, DOUBLE‐BLIND, MULTICENTER STUDY OF RECOMBINANT ADAMTS13 IN PATIENTS WITH IMMUNE‐MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA

Evans syndrome in adults: an observational multicenter study

Spanish consensus guidelines on prophylaxis with bypassing agents for surgery in patients with haemophilia and inhibitors

Multicenter assessment and longitudinal study of the prevalence of antibodies and related adaptive immune responses to AAV in adult males with hemophilia

Avatrombopag plus fostamatinib combination as treatment in patients with multirefractory immune thrombocytopenia

Multirefractory primary immune thrombocytopenia; targeting the decreased sialic acid content

Sustained Remission in Patients with Primary Immune Thrombocytopenia after Romiplostim Tapering and Discontinuation: A Case Series in Real Life Management in Spain

International recommendations on the diagnosis and treatment of patients with acquired hemophilia A

Efficacy and safety in patients with haemophilia A switching to octocog alfa (BAY 81–8973): Final results of the global real‐world study, TAURUS

BAY 81‐8973 prophylaxis and pharmacokinetics in haemophilia A: Interim results from the TAURUS study

Acquired Haemophilia A: A Review of What We Know

New treatments for primary immune thrombocytopenia

An update on the pathogenesis and diagnosis of thrombotic thrombocytopenic purpura

Sovleplenib in immune thrombocytopenia

Suchergebnisse filtern